Skip to main content
Clinical Trials/NL-OMON38933
NL-OMON38933CompletedNot Applicable

The role of the gut MIcrobiota in the SyStemic Immune respONse during human endotoxemia - MISSION-2

Academisch Medisch Centrum0 sites16 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
16

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • 1. Healthy (medical history, no use of medication; normal physical examination, ECG and laboratory tests)
  • 2. Male between 18 and 35 years of age
  • 3. Normal defecation pattern

Exclusion Criteria

  • 1. Recent major illness or chronic medical illness
  • 2. History of malignancy
  • 3. Gastrointestinal and liver diseases
  • 4. Known positive test for hepatitis B or C or HIV
  • 5. Smoking; drug abuse; alcohol abuse
  • 6. Clinically relevant ECG abnormality
  • 7. Subject has received an investigational product within three months of day 1 of the current study
  • 8. Use of prescription or non-prescription drugs
  • 9. Recent (< 12 months) use of antibiotics
  • 10. Allergy to antibiotics
  • 11. Difficultly in donating blood or limitied accessibility of a vein in left or right arm.
  • 12. Subject has donated more than 350 mL of blood in last 3 months
  • 13. Difficulty swallowing pills
  • 14. Body mass index >28 kg/m2

Investigators

Similar Trials